These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9826987)

  • 1. Botulinum toxin: chemistry, pharmacology, toxicity, and immunology.
    Brin MF
    Muscle Nerve Suppl; 1997; 6():S146-68. PubMed ID: 9826987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of botulinum toxin.
    Huang W; Foster JA; Rogachefsky AS
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 1):249-59. PubMed ID: 10906647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis.
    Kreyden OP; Scheidegger EP
    Clin Dermatol; 2004; 22(1):40-4. PubMed ID: 15158544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological effects of botulinum toxin in spasticity.
    Gracies JM
    Mov Disord; 2004 Mar; 19 Suppl 8():S120-8. PubMed ID: 15027064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxins in neurological disease.
    Comella CL; Pullman SL
    Muscle Nerve; 2004 May; 29(5):628-44. PubMed ID: 15116366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injection techniques for botulinum toxin using electromyography and electrical stimulation.
    O'Brien CF
    Muscle Nerve Suppl; 1997; 6():S176-80. PubMed ID: 9826989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current use of botulinum toxin.
    Mahant N; Clouston PD; Lorentz IT
    J Clin Neurosci; 2000 Sep; 7(5):389-94. PubMed ID: 10942658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of botulinum toxin type A in the treatment of cervical dystonia.
    Comella CL; Jankovic J; Brin MF
    Neurology; 2000; 55(12 Suppl 5):S15-21. PubMed ID: 11188979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of cervical dystonia with botulinum toxin.
    Jankovic J
    Mov Disord; 2004 Mar; 19 Suppl 8():S109-15. PubMed ID: 15027062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related botulinum toxin effects on muscle fiber conduction velocity in non-injected muscles.
    Lange F; van Weerden TW; van der Hoeven JH
    Clin Neurophysiol; 2007 Nov; 118(11):2398-403. PubMed ID: 17897878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin: a deadly substance with great therapeutic effect.
    Holmes S
    Prof Nurse; 2003 Oct; 19(2):85-7. PubMed ID: 14593781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin: description of injection techniques and examination of controversies surrounding toxin diffusion.
    Lim EC; Seet RC
    Acta Neurol Scand; 2008 Feb; 117(2):73-84. PubMed ID: 17850405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Commercial preparations and handling of botulinum toxin type A and type B.
    Parish JL
    Clin Dermatol; 2003; 21(6):481-4. PubMed ID: 14759580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanism of action and therapeutic uses of botulinum and tetanus neurotoxins].
    Popoff MR; Marvaud JC; Raffestin S
    Ann Pharm Fr; 2001 May; 59(3):176-90. PubMed ID: 11427819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical presentation and management of antibody-induced failure of botulinum toxin therapy.
    Dressler D
    Mov Disord; 2004 Mar; 19 Suppl 8():S92-S100. PubMed ID: 15027060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacology of therapeutic botulinum toxin preparations.
    Dressler D; Benecke R
    Disabil Rehabil; 2007 Dec; 29(23):1761-8. PubMed ID: 18033601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of botulinum toxin activity: evaluation of the lethality assay.
    Pearce LB; Borodic GE; First ER; MacCallum RD
    Toxicol Appl Pharmacol; 1994 Sep; 128(1):69-77. PubMed ID: 8079356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin, Quo Vadis?
    Lim EC; Seet RC
    Med Hypotheses; 2007; 69(4):718-23. PubMed ID: 17499937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of SNAP-25 by botulinum toxin type A requires receptor-mediated endocytosis, pH-dependent translocation, and zinc.
    Kalandakanond S; Coffield JA
    J Pharmacol Exp Ther; 2001 Mar; 296(3):980-6. PubMed ID: 11181932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.